The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
PMV Pharmaceuticals, Inc
PMV Pharmaceuticals, Inc
Inhibrx Biosciences, Inc
VM Oncology, LLC
University of Cincinnati
Maastricht University Medical Center
National Institutes of Health Clinical Center (CC)
M.D. Anderson Cancer Center
Rapa Therapeutics LLC
Intensity Therapeutics, Inc.
Alentis Therapeutics AG
Psivac Ltd
NextCure, Inc.
Atara Biotherapeutics
iTeos Therapeutics
GeneMedicine Co., Ltd.
SQZ Biotechnologies
SecuraBio
Kineta Inc.
Incyte Corporation
Dynavax Technologies Corporation
University of Cincinnati
MultiVir, Inc.